Comments
Loading...
Biodexa Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:BDRX | Benzinga
Biodexa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 30
EPS
$-25.000
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Biodexa Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BDRX | Biodexa Pharmaceuticals | -$246.60 | — | — | — | $469.79K | — | — | — | 05/13/2025 | Get Alert |
| BDRX | Biodexa Pharmaceuticals | -$496.50 | — | -$25.00 | — | $369.97K | — | $0.00 | — | 09/30/2024 | Get Alert |
| BDRX | Biodexa Pharmaceuticals | -$239.75 | — | -$246.60 | — | $865.09K | — | $469.79K | — | 04/19/2024 | Get Alert |
| BDRX | Biodexa Pharmaceuticals | -$5.00 | — | -$496.50 | — | $608.39K | — | $369.97K | — | 09/29/2023 | Get Alert |
| BDRX | Biodexa Pharmaceuticals | — | — | -$239.75 | — | — | — | $865.09K | — | 05/22/2023 | Get Alert |
| BDRX | Biodexa Pharmaceuticals | — | — | -$5.00 | — | — | — | $608.39K | — | 09/14/2022 | Get Alert |
Biodexa Pharmaceuticals (BDRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Biodexa Pharmaceuticals (BDRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals (BDRX) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on September 30, 2024 for H1.
What were the latest earnings per share (EPS) for Biodexa Pharmaceuticals (NASDAQ:BDRX)?
The Actual EPS was $-25.00, which missed the estimate of $0.00.
What were Biodexa Pharmaceuticals’s (NASDAQ:BDRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
